Fallarino F - Search Results

1

Modulation of tryptophan catabolism by regulatory T cells.

Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Puccetti P. Fallarino F, et al. Nat Immunol. 2003 Dec;4(12):1206-12. doi: 10.1038/ni1003. Epub 2003 Oct 26. Nat Immunol. 2003. PMID: 14578884

2

CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide.

Grohmann U, Bianchi R, Fioretti MC, Fallarino F, Binaglia L, Uyttenhove C, Van Pel A, Boon T, Puccetti P. Grohmann U, et al. Among authors: fallarino f. Eur J Immunol. 1995 Oct;25(10):2797-802. doi: 10.1002/eji.1830251013. Eur J Immunol. 1995. PMID: 7589074

3

[3H]aniracetam binds to specific recognition sites in brain membranes.

Fallarino F, Genazzani AA, Silla S, L'Episcopo MR, Camici O, Corazzi L, Nicoletti F, Fioretti MC. Fallarino F, et al. J Neurochem. 1995 Aug;65(2):912-8. doi: 10.1046/j.1471-4159.1995.65020912.x. J Neurochem. 1995. PMID: 7616253

4

Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor.

Grohmann U, Puccetti P, Belladonna ML, Fallarino F, Bianchi R, Binaglia L, Sagakuchi K, Mage MG, Appella E, Fioretti MC. Grohmann U, et al. Among authors: fallarino f. J Immunol. 1995 May 1;154(9):4630-41. J Immunol. 1995. PMID: 7722315

5

IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.

Bianchi R, Grohmann U, Belladonna ML, Silla S, Fallarino F, Ayroldi E, Fioretti MC, Puccetti P. Bianchi R, et al. Among authors: fallarino f. J Immunol. 1996 Aug 15;157(4):1589-97. J Immunol. 1996. PMID: 8759743

6

IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha- dendritic cells via potentiation of the CD8 alpha+ subset.

Grohmann U, Bianchi R, Belladonna ML, Silla S, Fallarino F, Fioretti MC, Puccetti P. Grohmann U, et al. Among authors: fallarino f. J Immunol. 2000 Aug 1;165(3):1357-63. doi: 10.4049/jimmunol.165.3.1357. J Immunol. 2000. PMID: 10903738

7

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo.

Fallarino F, Grohmann U, Bianchi R, Vacca C, Fioretti MC, Puccetti P. Fallarino F, et al. J Immunol. 2000 Nov 15;165(10):5495-501. doi: 10.4049/jimmunol.165.10.5495. J Immunol. 2000. PMID: 11067902

8

CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells.

Grohmann U, Fallarino F, Silla S, Bianchi R, Belladonna ML, Vacca C, Micheletti A, Fioretti MC, Puccetti P. Grohmann U, et al. Among authors: fallarino f. J Immunol. 2001 Jan 1;166(1):277-83. doi: 10.4049/jimmunol.166.1.277. J Immunol. 2001. PMID: 11123303

9

Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase.

Gajewski TF, Fallarino F, Fields PE, Rivas F, Alegre ML. Gajewski TF, et al. Among authors: fallarino f. J Immunol. 2001 Mar 15;166(6):3900-7. doi: 10.4049/jimmunol.166.6.3900. J Immunol. 2001. PMID: 11238634

10

Transplantation and the CD28/CTLA4/B7 pathway.

Alegre M, Fallarino F, Zhou P, Frauwirth K, Thistlethwaite J, Newell K, Gajewski T, Bluestone J. Alegre M, et al. Among authors: fallarino f. Transplant Proc. 2001 Feb-Mar;33(1-2):209-11. doi: 10.1016/s0041-1345(00)01977-1. Transplant Proc. 2001. PMID: 11266782 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters